Since the 1980s, CIWEC's clinicians have published on diarrheal disease, altitude illness, rabies and the health of travelers. These are the findings that mattered most.
CIWEC's doctors and laboratory described an unknown "alga-like organism" behind an outbreak of prolonged diarrhea among foreigners in Nepal. The organism was later named Cyclospora cayetanensis. CIWEC went on to define its epidemiology and to run the trial that established the first effective treatment.
One of the first systematic studies of the organisms behind diarrhea in travelers and foreign residents in Nepal — groundwork for how it is diagnosed and treated here today.
The first look at helicopter rescues and deaths among trekkers in Nepal, followed by a study of causes of death. Altitude illness emerged as a leading, preventable cause.
Showed the clinical importance of Salmonella Paratyphi A in Nepal — a cause of enteric fever that typhoid vaccination does not protect against.
Quantified the risk of possible rabies exposure among tourists and foreign residents in Nepal, shaping pre-travel vaccine advice for the region.
Reported the Kathmandu experience treating severe frostbite in extreme-altitude climbers with iloprost — one of the largest field series of its kind.
The only organization to have fielded two presidents of the International Society of Travel Medicine.
Our research comes straight from the exam room: questions raised by real patients, answered in our own lab and published so travelers everywhere benefit.
